Literature DB >> 7933138

Thermolysin activation mutants with changes in the fusogenic region of an influenza virus hemagglutinin.

M Orlich1, R Rott.   

Abstract

Influenza virus A/seal/Mass/1/80 (H7N7) mutants were obtained; the hemagglutinins (HAs) of the mutants were not activated by trypsin, as in the wild-type virus, but by thermolysin. The mutants grew efficiently under multiple replication cycle conditions and formed plaques in chicken embryo cells only when thermolysin was added to the culture medium. They exhibited hemolytic activity and induced protective immunity in chickens after an asymptomatic course of infection. Nucleotide sequencing of the HA gene and direct amino acid sequencing showed that insertion of a single leucine into the fusion peptide of the HA2 chain close to the cleavage site and a shift of the cleavage site toward the C terminus by one amino acid were responsible for the changes in the biological properties of the thermolysin activation mutants. Revertants could be obtained when trypsin or trypsin-like endoproteases were present in the virus-producing system.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7933138      PMCID: PMC237197     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  17 in total

1.  Enhancement of the infectivity of influenza A and B viruses by proteolytic cleavage of the hemagglutinin polypeptide.

Authors:  S G Lazarowitz; P W Choppin
Journal:  Virology       Date:  1975-12       Impact factor: 3.616

2.  The structure of the hemagglutinin, a determinant for the pathogenicity of influenza viruses.

Authors:  F X Bosch; M Orlich; H D Klenk; R Rott
Journal:  Virology       Date:  1979-05       Impact factor: 3.616

3.  Fusion mutants of the influenza virus hemagglutinin glycoprotein.

Authors:  R S Daniels; J C Downie; A J Hay; M Knossow; J J Skehel; M L Wang; D C Wiley
Journal:  Cell       Date:  1985-02       Impact factor: 41.582

Review 4.  The structure and function of the hemagglutinin membrane glycoprotein of influenza virus.

Authors:  D C Wiley; J J Skehel
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

5.  Sequence of the hemagglutinin gene from influenza virus A/Seal/Mass/1/80.

Authors:  C W Naeve; R G Webster
Journal:  Virology       Date:  1983-09       Impact factor: 3.616

6.  Proteolytic activation of the influenza virus hemagglutinin: The structure of the cleavage site and the enzymes involved in cleavage.

Authors:  W Garten; F X Bosch; D Linder; R Rott; H D Klenk
Journal:  Virology       Date:  1981-12       Impact factor: 3.616

7.  Role of Staphylococcus protease in the development of influenza pneumonia.

Authors:  M Tashiro; P Ciborowski; H D Klenk; G Pulverer; R Rott
Journal:  Nature       Date:  1987 Feb 5-11       Impact factor: 49.962

Review 8.  The pathogenic determinant of influenza virus.

Authors:  R Rott
Journal:  Vet Microbiol       Date:  1992-11       Impact factor: 3.293

9.  Studies on the mechanism of membrane fusion: site-specific mutagenesis of the hemagglutinin of influenza virus.

Authors:  M J Gething; R W Doms; D York; J White
Journal:  J Cell Biol       Date:  1986-01       Impact factor: 10.539

Review 10.  The molecular biology of influenza virus pathogenicity.

Authors:  H D Klenk; R Rott
Journal:  Adv Virus Res       Date:  1988       Impact factor: 9.937

View more
  8 in total

1.  A specific point mutant at position 1 of the influenza hemagglutinin fusion peptide displays a hemifusion phenotype.

Authors:  H Qiao; R T Armstrong; G B Melikyan; F S Cohen; J M White
Journal:  Mol Biol Cell       Date:  1999-08       Impact factor: 4.138

2.  The complete influenza hemagglutinin fusion domain adopts a tight helical hairpin arrangement at the lipid:water interface.

Authors:  Justin L Lorieau; John M Louis; Ad Bax
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-02       Impact factor: 11.205

3.  Modification of the hemagglutinin cleavage site allows indirect activation of avian influenza virus H9N2 by bacterial staphylokinase.

Authors:  Longping V Tse; Gary R Whittaker
Journal:  Virology       Date:  2015-04-01       Impact factor: 3.616

4.  Comprehensive mutational analysis of the Moloney murine leukemia virus envelope protein.

Authors:  S M Rothenberg; M N Olsen; L C Laurent; R A Crowley; P O Brown
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

5.  Bioinformatic analysis of the genome of infectious salmon anemia virus associated with outbreaks with high mortality in Chile.

Authors:  L Cottet; M Cortez-San Martin; M Tello; E Olivares; A Rivas-Aravena; E Vallejos; A M Sandino; E Spencer
Journal:  J Virol       Date:  2010-09-01       Impact factor: 5.103

6.  Studies on influenza haemagglutinin fusion peptide mutants generated by reverse genetics.

Authors:  K J Cross; S A Wharton; J J Skehel; D C Wiley; D A Steinhauer
Journal:  EMBO J       Date:  2001-08-15       Impact factor: 11.598

7.  Studies of the membrane fusion activities of fusion peptide mutants of influenza virus hemagglutinin.

Authors:  D A Steinhauer; S A Wharton; J J Skehel; D C Wiley
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

8.  Influenza HA subtypes demonstrate divergent phenotypes for cleavage activation and pH of fusion: implications for host range and adaptation.

Authors:  Summer E Galloway; Mark L Reed; Charles J Russell; David A Steinhauer
Journal:  PLoS Pathog       Date:  2013-02-14       Impact factor: 6.823

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.